维纳类化合物的药理活性和药物输送系统的进展
Quanying Zhou1, Min Jin1, Yulong Cui1
1Shandong University of Traditional Chinese Medicine, Jinan, China.
Natural product research
|April 25, 2025
概括
温卡类化合物在癌症治疗中表现有前途,但面临局限性. 先进的药物输送系统和组合疗法正在提高其有效性,并减少副作用,以获得更好的癌症治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 来自 *Catharanthus roseus* 的葡萄酒类化合物 (VAs) 是关键的癌症化疗药物.
- 静脉血管对白血病和淋巴瘤有效,但由于副作用,生物可用性差以及多药性耐药性 (MDR),其临床用途有限.
研究的目的:
- 审查Vinca类化合物的药理活性成分.
- 要总结Vinca类化合物的化疗作用.
- 分析用于癌症治疗的Vinca类药物递送技术的最新进展.
主要方法:
- 文献审查Vinca类化合物的特性和应用.
- 对Vinca类化合物的药物递送系统 (纳米粒子,脂质体,SLN) 的研究进行分析.
- 对Vinca类化合物的组合治疗方法的检查.
主要成果:
- 葡萄酒类化合物在治疗各种癌症,包括白血病和霍奇金淋巴瘤方面表现出显著的疗效.
- 像纳米颗粒和脂质体这样的药物输送系统增强了Vinca类化合物的药物动力学特性和瘤向性.
- 组合疗法可以减轻Vinca类化合物的副作用,并改善治疗结果.
结论:
- 药物输送系统和组合疗法为克服Vinca类化合物的癌症治疗局限性提供了有希望的策略.
- 对这些先进方法的进一步研究对于优化Vinca化物在临床瘤学中的应用至关重要.
- 本综述为未来的研究和Vinca类化合物在癌症治疗中的临床使用提供了参考.
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Drug Delivery: Overview
248
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
248
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
184
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
184
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
385
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
385


